Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Jun;80(8):1197–1203. doi: 10.1038/sj.bjc.6690486

Apoptosis is induced in both drug-sensitive and multidrug-resistant hepatoma cells by somatostatin analogue TT-232

C-C Diaconu 1, M Szathmári 1, G Kéri 2, A Venetianer 1
PMCID: PMC2362376  PMID: 10376972

Abstract

Clinical resistance to chemotherapeutic drugs is an important problem in the treatment of cancer; the circumvention of resistance has become one of the basic goals of cancer therapy. The most frequent form of primary liver cancer is hepatocellular carcinoma, which is essentially refractory to chemotherapy. We earlier showed that TT-232, a new somatostatin analogue developed in our laboratory, exerted a strong antiproliferative effect both in vitro and in vivo, but no growth hormone release inhibitory or antisecretory activity. Here we report that TT-232 has a pronounced antiproliferative effect on differentiated and dedifferentiated, drug-sensitive and multidrug-resistant hepatocellular carcinoma cell lines. TT-232 induces apoptosis at comparable levels in all these hepatoma variants demonstrating that the multidrug resistance of hepatomas does not correlate with a reduced susceptibility to apoptosis induction. These results clearly reveal that the machinery involved in apoptosis is functional in both drug-sensitive and resistant hepatoma variants and can be activated by the somatostatin analogue TT-232. © 1999 Cancer Research Campaign

Keywords: somatostatin analogue, apoptosis, hepatoma, multidrug-resistant

Full Text

The Full Text of this article is available as a PDF (181.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arends M. J., Wyllie A. H. Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol. 1991;32:223–254. doi: 10.1016/b978-0-12-364932-4.50010-1. [DOI] [PubMed] [Google Scholar]
  2. Bonfoco E., Ceccatelli S., Manzo L., Nicotera P. Colchicine induces apoptosis in cerebellar granule cells. Exp Cell Res. 1995 May;218(1):189–200. doi: 10.1006/excr.1995.1147. [DOI] [PubMed] [Google Scholar]
  3. Brazeau P., Vale W., Burgus R., Ling N., Butcher M., Rivier J., Guillemin R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science. 1973 Jan 5;179(4068):77–79. doi: 10.1126/science.179.4068.77. [DOI] [PubMed] [Google Scholar]
  4. Deschatrette J., Weiss M. C. Characterization of differentiated and dedifferentiated clones from a rat hepatoma. Biochimie. 1974;56(11-12):1603–1611. doi: 10.1016/s0300-9084(75)80286-0. [DOI] [PubMed] [Google Scholar]
  5. Dyson J. E., Simmons D. M., Daniel J., McLaughlin J. M., Quirke P., Bird C. C. Kinetic and physical studies of cell death induced by chemotherapeutic agents or hyperthermia. Cell Tissue Kinet. 1986 May;19(3):311–324. doi: 10.1111/j.1365-2184.1986.tb00683.x. [DOI] [PubMed] [Google Scholar]
  6. Endicott J. A., Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem. 1989;58:137–171. doi: 10.1146/annurev.bi.58.070189.001033. [DOI] [PubMed] [Google Scholar]
  7. Fardel O., Lecureur V., Guillouzo A. Regulation by dexamethasone of P-glycoprotein expression in cultured rat hepatocytes. FEBS Lett. 1993 Jul 26;327(2):189–193. doi: 10.1016/0014-5793(93)80167-s. [DOI] [PubMed] [Google Scholar]
  8. Fisher D. E. Apoptosis in cancer therapy: crossing the threshold. Cell. 1994 Aug 26;78(4):539–542. doi: 10.1016/0092-8674(94)90518-5. [DOI] [PubMed] [Google Scholar]
  9. Fry D. W., Kraker A. J., McMichael A., Ambroso L. A., Nelson J. M., Leopold W. R., Connors R. W., Bridges A. J. A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science. 1994 Aug 19;265(5175):1093–1095. doi: 10.1126/science.8066447. [DOI] [PubMed] [Google Scholar]
  10. Golstein P. Controlling cell death. Science. 1997 Feb 21;275(5303):1081–1082. doi: 10.1126/science.275.5303.1081. [DOI] [PubMed] [Google Scholar]
  11. Gottesman M. M. How cancer cells evade chemotherapy: sixteenth Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res. 1993 Feb 15;53(4):747–754. [PubMed] [Google Scholar]
  12. Jaspers H., Horvåth A., Mezö I., Kéri G., Van Binst G. Conformational study of a series of somatostatin analogues with antitumor and/or GH inhibitory activity. Int J Pept Protein Res. 1994 Mar;43(3):271–276. doi: 10.1111/j.1399-3011.1994.tb00390.x. [DOI] [PubMed] [Google Scholar]
  13. Kéri G., Erchegyi J., Horváth A., Mezõ I., Idei M., Vántus T., Balogh A., Vadász Z., Bökönyi G., Seprõdi J. A tumor-selective somatostatin analog (TT-232) with strong in vitro and in vivo antitumor activity. Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12513–12518. doi: 10.1073/pnas.93.22.12513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kéri G., Mezô I., Vadász Z., Horváth A., Idei M., Vántus T., Balogh A., Bökönyi G., Bajor T., Teplán I. Structure-activity relationship studies of novel somatostatin analogs with antitumor activity. Pept Res. 1993 Sep-Oct;6(5):281–288. [PubMed] [Google Scholar]
  15. Kéri G., Mezö I., Horváth A., Vadász Z., Balogh A., Idei M., Vántus T., Teplán I., Mák M., Horváth J. Novel somatostatin analogs with tyrosine kinase inhibitory and antitumor activity. Biochem Biophys Res Commun. 1993 Mar 15;191(2):681–687. doi: 10.1006/bbrc.1993.1271. [DOI] [PubMed] [Google Scholar]
  16. Laurent-Crawford A. G., Krust B., Muller S., Rivière Y., Rey-Cuillé M. A., Béchet J. M., Montagnier L., Hovanessian A. G. The cytopathic effect of HIV is associated with apoptosis. Virology. 1991 Dec;185(2):829–839. doi: 10.1016/0042-6822(91)90554-o. [DOI] [PubMed] [Google Scholar]
  17. Levitzki A., Gazit A. Tyrosine kinase inhibition: an approach to drug development. Science. 1995 Mar 24;267(5205):1782–1788. doi: 10.1126/science.7892601. [DOI] [PubMed] [Google Scholar]
  18. Mehlen P., Kretz-Remy C., Préville X., Arrigo A. P. Human hsp27, Drosophila hsp27 and human alphaB-crystallin expression-mediated increase in glutathione is essential for the protective activity of these proteins against TNFalpha-induced cell death. EMBO J. 1996 Jun 3;15(11):2695–2706. [PMC free article] [PubMed] [Google Scholar]
  19. Mosser D. D., Martin L. H. Induced thermotolerance to apoptosis in a human T lymphocyte cell line. J Cell Physiol. 1992 Jun;151(3):561–570. doi: 10.1002/jcp.1041510316. [DOI] [PubMed] [Google Scholar]
  20. Müller M., Strand S., Hug H., Heinemann E. M., Walczak H., Hofmann W. J., Stremmel W., Krammer P. H., Galle P. R. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest. 1997 Feb 1;99(3):403–413. doi: 10.1172/JCI119174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Patel Y. C., Greenwood M. T., Panetta R., Demchyshyn L., Niznik H., Srikant C. B. The somatostatin receptor family. Life Sci. 1995;57(13):1249–1265. doi: 10.1016/0024-3205(95)02082-t. [DOI] [PubMed] [Google Scholar]
  22. Pirity M., Hevér-Szabó A., Venetianer A. Overexpression of P-glycoprotein in heat- and/or drug-resistant hepatoma variants. Cytotechnology. 1996;19(3):207–214. doi: 10.1007/BF00744214. [DOI] [PubMed] [Google Scholar]
  23. Pirity M., Nguyen V. T., Dubois M. F., Bensaude O., Hevér-Szabó A., Venetianer A. Decreased stress inducibility of the HSP68 protein in a rat hepatoma variant clone. Eur J Biochem. 1992 Dec 15;210(3):793–800. doi: 10.1111/j.1432-1033.1992.tb17482.x. [DOI] [PubMed] [Google Scholar]
  24. Roehm N. W., Rodgers G. H., Hatfield S. M., Glasebrook A. L. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J Immunol Methods. 1991 Sep 13;142(2):257–265. doi: 10.1016/0022-1759(91)90114-u. [DOI] [PubMed] [Google Scholar]
  25. Schally A. V. Oncological applications of somatostatin analogues. Cancer Res. 1988 Dec 15;48(24 Pt 1):6977–6985. [PubMed] [Google Scholar]
  26. Scudiero D. A., Shoemaker R. H., Paull K. D., Monks A., Tierney S., Nofziger T. H., Currens M. J., Seniff D., Boyd M. R. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 1988 Sep 1;48(17):4827–4833. [PubMed] [Google Scholar]
  27. Sen S., D'Incalci M. Apoptosis. Biochemical events and relevance to cancer chemotherapy. FEBS Lett. 1992 Jul 27;307(1):122–127. doi: 10.1016/0014-5793(92)80914-3. [DOI] [PubMed] [Google Scholar]
  28. Venetianer A., Bajnoczky K., Gal A., Thompson E. B. Isolation and characterization of L-cell variants with altered sensitivity to glucocorticoids. Somatic Cell Genet. 1978 Sep;4(5):513–530. doi: 10.1007/BF01542923. [DOI] [PubMed] [Google Scholar]
  29. Venetianer A., Pintér Z., Gál A. Examination of glucocorticoid sensitivity and receptor content of hepatoma cell lines. Cytogenet Cell Genet. 1980;28(4):280–283. doi: 10.1159/000131541. [DOI] [PubMed] [Google Scholar]
  30. Venetianer A., Pirity M., Hever-Szabo A. The function of heat-shock proteins in stress tolerance. Cell Biol Int. 1994 Jun;18(6):605–615. doi: 10.1006/cbir.1994.1087. [DOI] [PubMed] [Google Scholar]
  31. Wyllie A. H., Kerr J. F., Currie A. R. Cell death: the significance of apoptosis. Int Rev Cytol. 1980;68:251–306. doi: 10.1016/s0074-7696(08)62312-8. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES